Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer

Chia Yu Chu, Jennifer Choi, Beth Eaby-Sandy, Corey J. Langer, Mario E. Lacouture*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences